U.S. Withdraws from WHO and Suspends Foreign Aid

On January 20, 2025, President Donald Trump signed an executive order initiating the United States’ withdrawal from the World Health Organization (WHO) and suspending all foreign aid for 90 days. This decision has sparked significant global concern and debate.

Reasons for Withdrawal from WHO

The executive order cites several reasons for the withdrawal:

Mishandling of the COVID-19 Pandemic: The U.S. administration criticized the WHO’s response to the pandemic, particularly its perceived leniency towards China’s initial handling of the outbreak.

Lack of Independence: Concerns were raised about the WHO’s susceptibility to political influence from member states, undermining its effectiveness in addressing global health issues.

Financial Disparities: The U.S. highlighted the disproportionate financial contributions, noting that despite having a smaller population than China, it contributed significantly more to the WHO’s budget.

Suspension of Foreign Aid

In addition to exiting the WHO, President Trump ordered a 90-day suspension of all U.S. foreign aid programs. This pause aims to reassess and realign aid distribution with U.S. foreign policy objectives. The administration expressed concerns that previous aid efforts may have inadvertently destabilized global peace by promoting ideas contrary to harmonious international relations.

Global Implications

The U.S. has been a major contributor to the WHO, providing approximately 18% of its budget. The withdrawal is expected to significantly impact global health initiatives, particularly in combating diseases like HIV, tuberculosis, and malaria. Countries and organizations reliant on U.S. funding may face substantial setbacks in their health programs.

International Reactions

Health experts and global leaders have expressed alarm over the U.S. decision. Germany’s health minister described the move as a serious setback to international health security. Critics argue that the withdrawal could undermine efforts to combat global health threats and weaken international cooperation.

Historical Context

This is not the first time the U.S. has signaled its intent to leave the WHO. In 2020, President Trump announced a similar withdrawal, citing comparable concerns. However, this decision was later reversed by President Joe Biden upon taking office.

Future Outlook

The withdrawal process is expected to take effect within a year. During this period, the U.S. plans to identify alternative partners to assume activities previously undertaken by the WHO. The suspension of foreign aid will undergo a comprehensive review to ensure alignment with current U.S. foreign policy goals.

Summary of the news

Category Key Points
Why in News U.S. announced withdrawal from WHO citing COVID-19 mishandling, financial disparities, and political influence concerns. Suspended all foreign aid for 90 days.
WHO Key Facts Founded: 1948; Headquarters: Geneva, Switzerland; Current Director-General: Tedros Adhanom Ghebreyesus.
U.S. Contributions to WHO U.S. contributed 18% of WHO’s budget, previously its largest donor.
Suspension of Aid Foreign aid paused for 90 days for reassessment of spending and alignment with U.S. foreign policy.
Historical Context Similar WHO withdrawal announced in 2020 under Trump but reversed by Biden in 2021.
Global Reaction Criticism from global leaders, including Germany, citing risks to international health security.
Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

13 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

13 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

14 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

15 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

15 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

16 hours ago